Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
WEX Inc ha un obiettivo di prezzo di consenso pari a $193.94, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da Mizuho, Barclays y UBS il agosto 1, 2025, julio 28, 2025 y julio 25, 2025. Con un obiettivo di prezzo medio di $180 tra le Mizuho, Barclays y UBS, c'è un implicito 5.08% upside per WEX Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/01/2025 | 8% | Mizuho | $150 → $185 | Maintains | Outperform | |||
07/28/2025 | -0.75% | Barclays | $135 → $170 | Maintains | Equal-Weight | |||
07/25/2025 | 8% | UBS | $138 → $185 | Maintains | Neutral | |||
07/25/2025 | -0.75% | Morgan Stanley | $142 → $170 | Maintains | Equal-Weight | |||
07/24/2025 | 15.59% | Baird | $186 → $198 | Maintains | Outperform | |||
07/17/2025 | -12.43% | Deutsche Bank | → $150 | Reinstates | → Hold | |||
05/27/2025 | -21.19% | Jefferies | $130 → $135 | Maintains | Hold | |||
05/02/2025 | -19.43% | UBS | $172 → $138 | Maintains | Neutral | |||
04/24/2025 | -18.27% | Wells Fargo | $160 → $140 | Maintains | Equal-Weight | |||
02/10/2025 | -0.75% | Mizuho | $215 → $170 | Maintains | Outperform | |||
02/10/2025 | -9.51% | Barclays | $200 → $155 | Maintains | Equal-Weight | |||
02/07/2025 | 16.76% | Keefe, Bruyette & Woods | $220 → $200 | Maintains | Outperform | |||
02/07/2025 | 0.41% | UBS | $200 → $172 | Maintains | Neutral | |||
02/07/2025 | -6.59% | Wells Fargo | $180 → $160 | Maintains | Equal-Weight | |||
02/07/2025 | — | William Blair | — | Downgrade | Outperform → Market Perform | |||
01/29/2025 | 25.52% | Mizuho | $220 → $215 | Maintains | Outperform | |||
01/22/2025 | 10.92% | Jefferies | $180 → $190 | Maintains | Hold | |||
01/14/2025 | 10.92% | Citigroup | $260 → $190 | Downgrade | Buy → Neutral | |||
01/06/2025 | 28.44% | Keefe, Bruyette & Woods | $247 → $220 | Maintains | Outperform | |||
12/17/2024 | 16.76% | Barclays | $207 → $200 | Downgrade | Overweight → Equal-Weight | |||
11/12/2024 | 28.44% | Mizuho | $200 → $220 | Maintains | Outperform | |||
10/28/2024 | 16.76% | Mizuho | $206 → $200 | Maintains | Outperform | |||
10/28/2024 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
10/25/2024 | 5.08% | Wells Fargo | $200 → $180 | Maintains | Equal-Weight | |||
10/25/2024 | 34.28% | Baird | $285 → $230 | Maintains | Outperform | |||
10/21/2024 | 16.76% | Wells Fargo | $190 → $200 | Maintains | Equal-Weight | |||
10/16/2024 | 22.6% | Jefferies | $190 → $210 | Maintains | Hold | |||
10/15/2024 | 48.87% | B of A Securities | $238 → $255 | Maintains | Buy | |||
08/20/2024 | 16.76% | JP Morgan | $210 → $200 | Maintains | Neutral | |||
07/29/2024 | 20.26% | Mizuho | $235 → $206 | Maintains | Outperform | |||
07/26/2024 | 10.92% | Wells Fargo | $200 → $190 | Maintains | Equal-Weight | |||
07/12/2024 | 22.6% | JP Morgan | $246 → $210 | Maintains | Neutral | |||
07/08/2024 | 34.28% | Keefe, Bruyette & Woods | $275 → $230 | Maintains | Outperform | |||
06/05/2024 | 16.76% | Wells Fargo | — | → $200 | Initiates | → Equal-Weight | ||
04/17/2024 | 63.47% | Citigroup | $240 → $280 | Maintains | Buy | |||
04/16/2024 | 63.47% | Barclays | $255 → $280 | Maintains | Overweight | |||
04/15/2024 | 66.38% | Baird | $272 → $285 | Maintains | Outperform | |||
04/12/2024 | 40.11% | Jefferies | $235 → $240 | Maintains | Hold | |||
03/26/2024 | 60.55% | Evercore ISI Group | $250 → $275 | Maintains | Outperform | |||
02/13/2024 | 37.19% | Mizuho | $225 → $235 | Maintains | Buy | |||
02/12/2024 | 48.87% | Barclays | $240 → $255 | Maintains | Overweight | |||
02/09/2024 | 28.44% | Truist Securities | $185 → $220 | Maintains | Hold | |||
02/09/2024 | 39.53% | JP Morgan | $205 → $239 | Maintains | Neutral | |||
01/18/2024 | 31.36% | Mizuho | $200 → $225 | Maintains | Buy | |||
10/31/2023 | 16.76% | Mizuho | $225 → $200 | Maintains | Buy | |||
10/30/2023 | 31.36% | Barclays | $245 → $225 | Maintains | Overweight | |||
10/27/2023 | 16.76% | Morgan Stanley | $205 → $200 | Maintains | Equal-Weight | |||
10/24/2023 | 19.68% | Morgan Stanley | $200 → $205 | Maintains | Equal-Weight | |||
10/17/2023 | 40.11% | Wolfe Research | → $240 | Upgrade | Peer Perform → Outperform | |||
10/04/2023 | 40.11% | Citigroup | $230 → $240 | Maintains | Buy | |||
09/21/2023 | 60.55% | Baird | $252 → $275 | Maintains | Outperform | |||
08/22/2023 | 36.03% | JP Morgan | $218 → $233 | Maintains | Neutral | |||
07/28/2023 | 22.6% | Credit Suisse | $195 → $210 | Maintains | Neutral | |||
07/07/2023 | 10.92% | Deutsche Bank | → $190 | Initiates | → Hold | |||
04/28/2023 | 10.92% | Truist Securities | $185 → $190 | Maintains | Hold | |||
04/28/2023 | 37.78% | Baird | $222 → $236 | Maintains | Outperform | |||
02/13/2023 | 34.28% | Citigroup | $190 → $230 | Maintains | Buy | |||
02/10/2023 | 28.44% | Mizuho | $200 → $220 | Reiterates | → Buy | |||
02/10/2023 | 25.52% | Truist Securities | $190 → $215 | Maintains | Hold | |||
02/10/2023 | 16.18% | Morgan Stanley | $157 → $199 | Maintains | Equal-Weight | |||
02/10/2023 | 29.6% | Baird | $200 → $222 | Maintains | Outperform | |||
01/25/2023 | 16.76% | Baird | $190 → $200 | Maintains | Outperform | |||
01/23/2023 | 22.02% | Barclays | $213 → $209 | Maintains | Overweight | |||
01/20/2023 | 10.92% | Truist Securities | $170 → $190 | Maintains | Hold | |||
01/09/2023 | 12.67% | Wells Fargo | $185 → $193 | Maintains | Overweight | |||
11/14/2022 | 16.76% | Mizuho | $220 → $200 | Maintains | Buy | |||
10/31/2022 | 24.35% | Barclays | $211 → $213 | Maintains | Overweight | |||
10/28/2022 | -8.34% | Morgan Stanley | $148 → $157 | Maintains | Equal-Weight | |||
10/28/2022 | 8% | Wells Fargo | $170 → $185 | Maintains | Overweight | |||
10/20/2022 | 5.08% | B of A Securities | $225 → $180 | Maintains | Buy | |||
10/13/2022 | -15.35% | Truist Securities | $185 → $145 | Maintains | Hold | |||
10/11/2022 | -13.6% | Morgan Stanley | $180 → $148 | Maintains | Equal-Weight | |||
09/15/2022 | 23.18% | Barclays | $220 → $211 | Maintains | Overweight | |||
09/08/2022 | 13.26% | Wells Fargo | $210 → $194 | Maintains | Overweight |
El último precio objetivo de WEX (NYSE:WEX) fue comunicado por Mizuho el agosto 1, 2025. La firma de analistas fijó un precio objetivo para $185.00 que espera WEX a rise dentro de 12 meses (un posible 8.00% upside). 28 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para WEX (NYSE:WEX) fue proporcionada por Mizuho, y WEX mantuvo su outperform calificación.
La última revisión al alza de WEX Inc se produjo en octubre 17, 2023, cuando Wolfe Research elevó su precio objetivo a $240. Wolfe Research anteriormente tenía a peer perform para WEX Inc.
La última revisión a la baja de WEX Inc se produjo en febrero 7, 2025, cuando William Blair cambió su precio objetivo de N/A a N/A para WEX Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de WEX, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de WEX se registró el agosto 1, 2025, por lo que la próxima calificación estará disponible en torno al agosto 1, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de WEX (WEX) fue un mantuvo con un precio objetivo de $150.00 a $185.00. El precio actual al que cotiza WEX (WEX) es de $171.29, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.